Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 11
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/23/2008
 
First Published:
11/25/2005
1.
Phase I/II Study of Green Tea Extract (Polyphenon E) in Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
NCI
MAYO-MC0419
7303, NCI-7303, NCT00262743, CLLT-MAYO-MC0419
2.
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Other
H06-128
IND78,248, NCT00707252
Last Modified:
10/31/2008
 
First Published:
3/13/2006
3.
Phase II Randomized Study of Green Tea Extract (Polyphenon E®) for the Prevention of Cervical Cancer in Patients With Human Papillomavirus (HPV) and Low-Grade Cervical Intraepithelial Neoplasia (CIN 1)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Active
18 and over
NCI
UARIZ-UAZ03-1-02
UARIZ-HSC-0540, UAZ03-1-02, NCT00303823
Last Modified:
6/10/2008
 
First Published:
8/6/2006
4.
Phase II Randomized Study of Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Prevention
Active
40 to 80
NCI
UARIZ-HSC-0353
U01-CA-101204, NCT00363805
Last Modified:
4/24/2008
 
First Published:
2/7/2008
5.
Phase II Randomized Study of Polyphenon E, A Defined Green Tea Catechin Extract, in Current or Former Smokers With Bronchial Dysplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Prevention
Active
45 to 74
NCI
BCCA-H07-02401
H07-02401, NCT00611650
Last Modified:
7/3/2008
 
First Published:
4/23/2008
6.
Phase II Randomized Study of Neoadjuvant Polyphenon® E (Defined Green Tea Catechin Extract) in Patients With Nonmetastatic Bladder Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
WCCC-UWI06-8-01
UWI06-8-01, CO06810, H2007-0250, 07-1270-03, NCT00666562
7.
Study of Polyphenon E in Men With High-Grade Prostatic Intraepithelial Neoplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Active
30 to 80
NCI, Other
MCC 15008
USF#105730, NCT00596011
8.
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
21 to 75
Other
H04-179
NCT00676793
Last Modified:
12/8/2008
 
First Published:
9/23/2005
9.
Phase IB Randomized Study of Green Tea Extract (Polyphenon E) in Preventing Esophageal Cancer in Patients With Barrett’s Esophagus
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Prevention
Active
18 and over
NCI
MDA-03101
NCT00233935, MDA03-101, MDA-2004-0907, CPMC-AAA0407
Last Modified:
6/13/2008
 
First Published:
4/2/2007
10.
Phase I Study of Defined Green Tea Catechin Extract in Patients With Prostate Cancer Scheduled to Undergo Prostatectomy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
UARIZ-UAZ05-6-01
UAZ05-6-01, HSC# 06-0695-04, UARIZ-HSC-06-0695-04, NCT00459407
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute